United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar MFClobberMeSilly (70.58) Submitted: 11/9/2007 8:27:36 AM : Outperform Start Price: $50.01 UTHR Score: -6.92

Best biomed

Featured Broker Partners


Advertisement